ArticleCancer research2023

CRISPR Screening Identifies Mechanisms of Resistance to KRASG12C and SHP2 Inhibitor Combinations in Non-Small Cell Lung Cancer.

Anirudh Prahallad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.